Display Settings:

Format

Send to:

Choose Destination
Addict Behav. 2008 Dec;33(12):1602-5. doi: 10.1016/j.addbeh.2008.07.005. Epub 2008 Jul 22.

Injecting drug users' understanding of hepatitis C.

Author information

  • 1National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia. s.obrien@unsw.edu.au

Abstract

This cross-sectional survey examined IDUs' understanding of HCV, their knowledge of virus transmission, clinical markers, symptoms and treatment. IDUs were recruited through and interviewed at a range of settings in inner-city, suburban and regional sites of New South Wales, Australia; 149 IDUs were recruited. Recent HCV testing was reported by 74% of participants, but a number of IDUs were confused about the results of the various tests, e.g. 19% of participants who stated they had HCV believed they could not infect others or were immune. Significant gaps in IDUs' knowledge of HCV were uncovered with respect to transmission risks (48% believed HCV could be contracted from re-using one's own, unshared needle), symptoms and clinical markers (42% believed HCV antibodies gave protection against HCV infection), and treatment. Findings warrant further development of, and research into, strategies to improve IDUs' understanding of HCV.

PMID:
18762384
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk